Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samitabh Chakraborti

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Expert Review of Anti-Infective Therapy|January 31, 2006
Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related virusesZhongyu Zhu, Antony S Dimitrov, Samitabh Chakraborti, et al.
Experimental and Molecular Pathology|January 22, 2008
Membrane activity of an amphiphilic alpha-helical membrane-proximal cytoplasmic domain of the MoMuLV envelope glycoproteinRaquel F Epand, Yan-Liang Zhang, Tajib Mirzabekov, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2021
Development of potent and selective Cathepsin C inhibitors free of aortic binding liability by application of a conformational restriction strategyAbhisek Banerjee, Ranganadh Velagaleti, Sandip Patil, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2018
Discovery of 5-(2-chloro-4'-(1H-imidazol-1-yl)-[1,1'-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPDNagarajan Muthukaman, Sanjay Deshmukh, Shital Tondlekar, et al.
Mabs|January 30, 2025
Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidityJeremy Loyau, Thierry Monney, Marco Montefiori, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2007
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesZhongyu Zhu, Samitabh Chakraborti, Yuxian He, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Expert Review of Anti-Infective Therapy|January 31, 2006
Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related virusesZhongyu Zhu, Antony S Dimitrov, Samitabh Chakraborti, et al.
Experimental and Molecular Pathology|January 22, 2008
Membrane activity of an amphiphilic alpha-helical membrane-proximal cytoplasmic domain of the MoMuLV envelope glycoproteinRaquel F Epand, Yan-Liang Zhang, Tajib Mirzabekov, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2021
Development of potent and selective Cathepsin C inhibitors free of aortic binding liability by application of a conformational restriction strategyAbhisek Banerjee, Ranganadh Velagaleti, Sandip Patil, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2018
Discovery of 5-(2-chloro-4'-(1H-imidazol-1-yl)-[1,1'-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPDNagarajan Muthukaman, Sanjay Deshmukh, Shital Tondlekar, et al.
Mabs|January 30, 2025
Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidityJeremy Loyau, Thierry Monney, Marco Montefiori, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2007
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesZhongyu Zhu, Samitabh Chakraborti, Yuxian He, et al.
Pageof 2